Team joins national network focused on neurodegenerative disorders
Scientists who recently identified the molecular start of Alzheimer’s disease have used that finding to determine that it should be possible to forecast which type of dementia will develop over time – a form of personalized medicine for neurodegenerative diseases.
A new study from UT Southwestern shows that single toxic tau proteins that stick together and spread degeneration across the brains of dementia patients have different shapes. The folds of these molecules hold information that could help diagnose – and perhaps one day treat – neurodegeneration in its earliest stages.
The finding comes from a team of scientists appointed this month to a newly created network of international collaborators focused on improving treatment of neurodegenerative disorders. Funded by the Chan Zuckerberg Initiative, the UT Southwestern group is tasked with using its recent discoveries of the tau protein to develop clinical diagnostic tools.
“Our expanded understanding of the tau protein structure changes how we think about detecting and treating Alzheimer’s disease and related dementias,” said Dr. Marc Diamond, Director of UT Southwestern’s Center for Alzheimer’s and Neurodegenerative Diseases. “The next step is to translate this knowledge into simple clinical tests that doctors will use to diagnose and eventually stop the neurodegeneration process at its earliest stages.”
Dr. Diamond’s new study expands on research published in July from his lab that documented a structural “genesis” of Alzheimer’s disease – the basis of how a healthy tau protein changes shape and is then capable of assembling with other tau molecules to kill brain cells.
The latest study published in eLife shows that harmful single tau molecules take different shapes that each correlates to a distinct type of larger assembly that will form and self-replicate across the brain. Dr. Diamond’s lab already established in a 2016 study that the structure of larger tau assemblies determines which type of dementia will occur – which regions of the brain will be affected and how quickly the disease will spread. But it was unknown what specified these larger structures. The new research reveals how a single tau molecule that changes shape at the beginning of the disease process contains the information that determines the configuration of the larger, toxic assemblies. This finding suggests that characterization of the conformation of single tau molecules could predict what incipient disease is occurring – Alzheimer’s or other types of dementia.
Scientists made these discoveries by extracting tau protein from cultured cells and human brains, isolating them as single molecules and determining what types of pathological assemblies they would subsequently produce in cells and mice. They determined that contrary to prior ideas, a single tau molecule, rather than being without definable structure, in fact has multiple, stable structures that each determine what type of subsequent pathological assembly it will form.
Dr. Diamond’s team is trying to translate these findings into clinical tests that examine a patient’s blood or spinal fluid to detect the first biological signs of the abnormal tau, before the symptoms of memory loss and cognitive decline become apparent. His lab is also working to develop treatments to stabilize shape-shifting tau molecules, prevent them from assembling, or promote their clearance from the brain.
A diagnostic test will be especially important once effective treatments are established to treat various forms of dementia, he said.
“It’s probably too late once the effects of neurodegeneration are manifest,” said Dr. Diamond, a leading dementia expert credited with determining that tau acts like a prion – an infectious protein that can self-replicate. “We need to be able to diagnose the process early and know the specific type of neurodegeneration that is occurring, because that is the best chance we have to intervene with a personalized treatment. This is very analogous to how we currently use tumor genotyping to best diagnose and treat cancer.”
Learn more: New discoveries predict ability to forecast dementia from single molecule
The Latest on: Neurodegeneration
[google_news title=”” keyword=”neurodegeneration” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Neurodegeneration
- Calico and Broad Institute Extend Collaboration Adding Focus on Age-Related Neurodegenerationon May 9, 2024 at 4:30 am
Calico Life Sciences LLC (Calico) and the Broad Institute of MIT and Harvard, announced today that the two organizations have further extended their partnership with an added focus on age-related ...
- Youth-onset diabetes linked to higher Alzheimer's riskon May 8, 2024 at 10:29 pm
Young people with diabetes may have a significantly higher risk of developing Alzheimer's disease later in life, according to a new study by researchers in the Lifecourse Epidemiology of Adiposity and ...
- Diabetes in youth may increase risk for neurodegenerative disease, like Alzheimer's disease, later in lifeon May 8, 2024 at 2:04 pm
Young people with diabetes may have a significantly higher risk of developing Alzheimer's disease later in life, according to a new study by researchers in the Lifecourse Epidemiology of Adiposity and ...
- Inflammation may be behind infection-dementia link: studyon May 7, 2024 at 5:00 pm
People with previous infections are nearly three times more likely to develop dementia compared to those without infections, and more infections are tied to a greater risk for neurodegeneration, a new ...
- Coral Sanfeliu, aging researcher: ‘Sitting eight hours a day affects brain connections’on May 7, 2024 at 10:52 am
The scientist has just published a book on the positive effects of exercise on brain health and the genetic mechanisms that are activated in response to physical activity ...
- The role of inflammatory processes in neurodegeneration: cellular, tissue and systemic mechanismson May 6, 2024 at 7:23 am
Neuroinflammatory and neurodegenerative disorders affect millions of people worldwide, but the pathophysiological aspects of most of them remain poorly understood. Neuroinflammation is characterized ...
- Belfer family’s $20 million donation invigorates neurodegeneration research at MD Andersonon May 5, 2024 at 5:00 pm
HOUSTON ― Laurence Belfer, on behalf of Robert Belfer and the Belfer family, today announced a $20 million gift to The University of Texas MD Anderson Cancer Center to strengthen neurodegeneration ...
- New Research Links Reused Deep-Fried Oil Linked to Neurodegenerationon May 1, 2024 at 2:05 am
A study on animals indicates that consumption of grease interferes with the connections between the liver, gut, and brain. A recent study revealed increased neurodegeneration in rats and their ...
- Neurodegeneration News and Researchon April 29, 2024 at 5:00 pm
This finding will pave the way for novel therapeutic approaches in neuroprotection against aging-related disorders and neurodegeneration. Study found that a high-fat diet exacerbates age-related ...
via Bing News